Acute Ischemic Stroke Diagnosis and Treatment Market Insights Video
According to Cognitive Market Research, the global Acute Ischemic Stroke Diagnosis and Treatment market size will be USD 5521.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.80% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 2208.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1656.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1269.95 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 276.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 110.43 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
Magnetic Resonance Imaging held the highest Acute Ischemic Stroke Diagnosis and Treatment market revenue share in 2024.
